BioTrack Capital is a venture capital firm established in 2017 and located in Shanghai, China. The company focuses on investing in the healthcare and life science sectors, targeting opportunities within China. Its primary goal is to support innovative companies that are advancing developments in these critical industries.
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
BangBang Robotics is a service provider of intelligent assistive devices dedicated to creating a new ecology for elderly care, assisting the disabled, and creating a better lifestyle for handicapped groups through technology. Telemedicine, home rehabilitation, and live auxiliary will be integrated to lead the development of assistive device 3.0 through the energization of intelligent technologies. The company owns a number of core independent intellectual property rights as well as approximately 100 patents. The Company's main product lines are home rehabilitation series, traveling auxiliary series, and nursing and physiotherapy series. In China, the company operates more than 100 experiential service stations.
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.
Founded in 2020, Cargene Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver fibrosis and ophthalmic disorders, with operations in Singapore, USA and China. Cargene uses proprietary platforms backed by novel biology and chemistry insights, Cargene aims to improve quality of life for millions of patients worldwide through creating highly specific, stable and potent nucleic acid-based medicines for the treatment of a broad range of diseases.
Move Vision Technology is a digital therapy and smart wearable device platform company. The company focuses on the full-cycle health management of cardiovascular diseases. As a technologically innovative enterprise in the field of cardiovascular health for life monitoring and digital therapy, the goal is to apply digital therapy in-depth in the early warning, monitoring and rehabilitation management of cardiovascular diseases. Through the interdisciplinary combination of clinical medicine, biomedical engineering, bioinformatics, etc., the research and development of multi-field software and hardware products will be completed.
Carcell Biopharma is a pre-clinical biotech company. Carcell Biopharma develops cell and gene therapy products with an innovative cross-border business model.
HC Scientific (Chengdu) L.L.C., established in early 2016, holds the mission of "Empowering Life Sciences, Achieving Excellence with Simplicity." We are dedicated to the development of intelligent solutions in the field of life technology, aspiring to be the most trusted partner for global life science clients. Committed to autonomous research and development of intellectual property, our company is a national high-tech enterprise encompassing equipment R&D, production, and market promotion. We are recognized as a key player in China's "Double Hundred Projects" for new economy development and have been designated by the Ministry of Human Resources and Social Security as an enterprise led by promising overseas returnees. Our company is actively involved in several national and provincial-level significant scientific and technological initiatives. With a team of distinguished experts, professors, and returning PhDs from the international arena, we've accomplished the development of intelligent life science technology platforms. Our product pipeline spans in vitro diagnostics, modern agriculture, scientific research, and more, significantly streamlining the complex tasks for practitioners in the life science field and creating substantial value for each of our collaborative partners.
Tendfo develops a medical device for pulmonary embolism interventional therapy. Tendfo mainly engages in R&D, manufacturing, and sales of innovative high-end medical devices for venous vascular intervention; technology development, technical consultation, technology transfer, technical services in the field of medical device technology, import and export of medical device goods or technologies, and medical device operation.
Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.
Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes.
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
SeekGene is a provider of genetic data analysis solutions focused on the development and clinical transformation of single cell sorting assays. The SeekGene operations team has many years of research and clinical service experience, focusing on the application of single-cell sequencing technology in real-world clinical research. Its self-developed high-throughput single-cell transcriptome sequencing kit achieves world-leading performance, and is flexible, simple, economical, and accurate, which can accelerate the clinical transformation of single-cell sequencing technology.
BioNova Pharma biopharmaceutical company that develops and commercializes innovative medicines for cancer and other life-threatening diseases. The company is expanding company with a strong pipeline based on in-house R&D initiatives, partnerships with, and purchases from partners with cutting-edge technology. The goal of BioNova is to close the gap between the high unmet medical needs and the dearth of innovative medicines by developing an innovative R&D platform with a substantial pipeline to address multiple disease areas.
CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.
Ezisurg Medical produces surgical medical devices. They are in the sector of medical technology, surgical procedures, and medical devices. They created four product lines including an anastomotic product line, an energy product line, an endoscopic system product line, a matching product line, a laparoscopic system product line, and a surgical support product line. The company's mission is to provide premium and affordable M.I.S. products to hospitals, surgeons and their patients.
Yunhu Health is a Chinese third-party medical testing service platform.Yunhu Technology is a grassroots medical inspection service platform. It mainly sends the inspection samples to the laboratory through the self-built cold chain logistics transportation system. After testing, analysis and review, the test results will be uploaded to the cloud call inspection service cloud platform. Customers can log on to the platform to download and view. The platform also provides accurate inspection services, health management services and value-added services such as inspection report interpretation and disease diagnosis and treatment recommendations to help improve the comprehensive diagnosis and treatment capabilities of primary medical institutions. Recently, according to the arterial network, cloud-based technology, the leader in the Internet service platform of the primary medical industry,
AccuMedical
Series A in 2019
AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.
As China’s leading healthcare platform, MediTrust has launched a range of diverse health insurance products and a broad array of medical and healthcare benefits and services. The Company effectively links pharmaceutical companies, insurers, hospitals and patients, forming a virtuous circle among payers, suppliers of products and services, and customers. By integrating high-quality medical and healthcare resources and health insurance, MediTrust provides families with economical, high quality, and personalized medical and healthcare services and protection.
Yunhu Health is a Chinese third-party medical testing service platform.Yunhu Technology is a grassroots medical inspection service platform. It mainly sends the inspection samples to the laboratory through the self-built cold chain logistics transportation system. After testing, analysis and review, the test results will be uploaded to the cloud call inspection service cloud platform. Customers can log on to the platform to download and view. The platform also provides accurate inspection services, health management services and value-added services such as inspection report interpretation and disease diagnosis and treatment recommendations to help improve the comprehensive diagnosis and treatment capabilities of primary medical institutions. Recently, according to the arterial network, cloud-based technology, the leader in the Internet service platform of the primary medical industry,
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.
Yunhu Health is a Chinese third-party medical testing service platform.Yunhu Technology is a grassroots medical inspection service platform. It mainly sends the inspection samples to the laboratory through the self-built cold chain logistics transportation system. After testing, analysis and review, the test results will be uploaded to the cloud call inspection service cloud platform. Customers can log on to the platform to download and view. The platform also provides accurate inspection services, health management services and value-added services such as inspection report interpretation and disease diagnosis and treatment recommendations to help improve the comprehensive diagnosis and treatment capabilities of primary medical institutions. Recently, according to the arterial network, cloud-based technology, the leader in the Internet service platform of the primary medical industry,
HC Scientific (Chengdu) L.L.C., established in early 2016, holds the mission of "Empowering Life Sciences, Achieving Excellence with Simplicity." We are dedicated to the development of intelligent solutions in the field of life technology, aspiring to be the most trusted partner for global life science clients. Committed to autonomous research and development of intellectual property, our company is a national high-tech enterprise encompassing equipment R&D, production, and market promotion. We are recognized as a key player in China's "Double Hundred Projects" for new economy development and have been designated by the Ministry of Human Resources and Social Security as an enterprise led by promising overseas returnees. Our company is actively involved in several national and provincial-level significant scientific and technological initiatives. With a team of distinguished experts, professors, and returning PhDs from the international arena, we've accomplished the development of intelligent life science technology platforms. Our product pipeline spans in vitro diagnostics, modern agriculture, scientific research, and more, significantly streamlining the complex tasks for practitioners in the life science field and creating substantial value for each of our collaborative partners.
Yuchen Guangyi
Series A in 2018
Yuchen Guangyi is a high-tech enterprise integrating research, development, production and sales of a new biomedical system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.